Editas Medicine, Inc. (EDIT)
2.12
-0.10
(-4.50%)
USD |
NASDAQ |
Jan 15, 10:03
Editas Medicine Price: 2.12 for Jan. 15, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ADMA Biologics, Inc. | 17.84 |
| Arcutis Biotherapeutics, Inc. | 26.71 |
| Daré Bioscience, Inc. | 2.03 |
| Cogent Biosciences, Inc. | 37.92 |
| Janux Therapeutics, Inc. | 13.80 |
Price Related Metrics
| PS Ratio | 3.887 |
| Price to Book Value | 15.38 |
| Earnings Yield | -112.1% |
| Market Cap | 206.95M |